Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.02 -0.05 (-2.42%)
At close: Oct 1, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Operating Expenses (2025 - 2026)

Updated

Polaryx Therapeutics' Operating Expenses came in at $1.38 million for Q2 2026, up 56.1% from $884,000 a year earlier but down 29.5% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Operating Expenses (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Polaryx Therapeutics reported Operating Expenses of $9.27 million; for FY2025, it came in at $7.82 million, up 79.7% from FY2024.

  • Going back by year, Operating Expenses was $4.35 million in FY2024.
  • The five-year range for quarterly Operating Expenses is $884,000 (Q2 2025) to $5.05 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Polaryx Therapeutics 103.18 Mn 78.80 Mn - 1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.38 Mn
Mar 31, 2026 1.96 Mn
Jun 30, 2025 884,000.00
Mar 31, 2025 5.05 Mn
API Access

Polaryx Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PLYX&period=max&api_key=YOUR_API_KEY